
- Telehealth Visits
- Insurance plan information

Kresta Ria A. Tabaranza, OD
She | Her | HersOptometry- Telehealth Visits
- Insurance plan information



Kresta Ria A. Tabaranza, OD
She | Her | HersOptometry- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Kresta Ria A. Tabaranza is an optometrist who provides comprehensive eye care to patients of all ages. She prescribes glasses and soft contact lenses to correct common problems causing unclear vision, including nearsightedness, farsightedness and astigmatism.
Tabaranza has experience in caring for people with a variety of eye issues, including glaucoma, macular degeneration (a disease that causes gradual vision loss), and tears or detachments of the retina (the layer of light-sensing cells at the back of the eye). She has a special interest in diagnosing eye changes linked to common conditions, including high blood sugar, high blood pressure and high cholesterol. She enjoys helping patients improve not only their vision but their overall health.
Tabaranza earned her doctor of optometry degree from the Herbert Wertheim School of Optometry & Vision Science at the University of California, Berkeley. She completed a residency in primary eye care at the Veterans Affairs San Diego Healthcare System.
Education & training
Residency
- Optometry, VA Medical Center - San Diego
Degree
- OD, University of California Berkeley
My expertise
Specialties
Conditions
- Retinal Detachment
- Macular Degeneration
- Glaucoma
- Astigmatism
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224754%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224754%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.